COMP <GO>
SMG vs LIN // FREE CASH FLOW YIELD
Scotts Miracle-Gro Company (The) (NYSE) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: SMG 7
— LIN 7
▲ FREE CASH FLOW YIELD LEADER: SMG
LAST: $62.24 (+0.60%) • MKT CAP: $3.60B
fcf-yield
7.60%
LAST: $514.24 (+2.20%) • MKT CAP: $231.94B
fcf-yield
2.19%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMG VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMG | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.60% | 41.00% | -10.40 | LIN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | 13.10% | +3.20 | SMG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 18.5x | -5.30 | SMG | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 7.60% | 2.19% | +5.41 | SMG | /fcf-yield <GO> |
| Operating Margin | 10.50% | 26.30% | -15.80 | LIN | /operating-margins <GO> |
| Net Profit Margin | 4.30% | 20.30% | -16.00 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) | -3.90% | 3.00% | -6.90 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.28% | 1.21% | +3.07 | SMG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.32 | 3.93 | -1.61 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.90% | +0.10 | LIN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.5 | 69.3 | +6.21 | SMG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 1.01 | +0.02 | SMG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.1x | 31.2x | -8.10 | SMG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.60B | $231.94B | -$228.34B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMG REV | LIN REV | SMG GROSS % | LIN GROSS % | SMG FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.41B | $33.99B | 30.6% | 44.0% | $273.9M | $5.09B |
| FY 2024 | $3.55B | $33.01B | 23.9% | 44.0% | $583.5M | $4.93B |
| FY 2023 | $3.55B | $32.85B | 44.0% | 44.0% | $371.2M | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMG // BETA 1.03
LIN // BETA 1.01